fbpx Skip to main content

Member's Profile

Karma Biotechnologies

370 Amapola Ave Ste 101
Torrance,   California
United States
Membership Info
Membership Type: Industry
Membership Since: 2017
Need to make an update to your Member Profile or have a question? Contact us here: [email protected]
About Karma Biotechnologies
Biotech Company
Therapies for autoimmune diseases are stuck in the 20th century – physicians can only alleviate a patient’s symptoms and they must cripple their entire immune system to do it. Karma was founded by a team of immune engineers, nanotech scientists, and company builders to create a better solution. We’re developing Xavines™, tolerogenic vaccines designed to shut down the self-attacking rogue immune cells while leaving the rest of the immune system functional. Karma recently closed a seed round led by Khosla Ventures that allowed us to hire an outstanding team of scientists and build out and equip excellent laboratory space. In addition to developing our own Xavine™ products, we can rapidly develop custom gene therapy delivery solutions for our commercial partners.
Related News
No related news posted by this Member